Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice

34Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The HIV-1 maturation inhibitor, 3-O-(3',3'-dimethylsuccinyl) betulinic acid (bevirimat, PA-457) is a promising drug candidate with 10 nM in vitro antiviral activity against multiple wild-type (WT) and drug-resistant HIV-1 isolates. Bevirimat has a novel mechanism of action, specifically inhibiting cleavage of spacer peptide 1 (SP1) from the C-terminus of capsid which results in defective core condensation.

Cite

CITATION STYLE

APA

Stoddart, C. A., Joshi, P., Sloan, B., Bare, J. C., Smith, P. C., Allaway, G. P., … Martin, D. E. (2007). Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice. PLoS ONE, 2(11). https://doi.org/10.1371/journal.pone.0001251

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free